Annovis Bio, Inc.

Annovis Bio, Inc.verified

ANVS

Price:

$1.78

Market Cap:

$35.02M

Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive cap...[Read more]

Industry

Biotechnology

IPO Date

2020-01-29

Stock Exchange

NYSE

Ticker

ANVS

The Enterprise Value as of June 2026 (TTM) for Annovis Bio, Inc. (ANVS) is 20.80M

According to Annovis Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.80M. This represents a change of -49.52% compared to the average of 41.20M of the last 4 quarters.

Annovis Bio, Inc. (ANVS) Historical Enterprise Value (quarterly & annually)

How has ANVS Enterprise Value performed in the past?

The mean historical Enterprise Value of Annovis Bio, Inc. over the last ten years is 69.39M. The current 20.80M Enterprise Value has changed 2.90% with respect to the historical average. Over the past ten years (40 quarters), ANVS's Enterprise Value was at its highest in in the June 2021 quarter at 581.24M. The Enterprise Value was at its lowest in in the March 2025 quarter at -3963175.00.

Quarterly (TTM)
Annual

Average

69.39M

Median

51.58M

Minimum

39.50M

Maximum

162.98M

Annovis Bio, Inc. (ANVS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Annovis Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 123.77%

Maximum Annual Enterprise Value = 162.98M

Minimum Annual Increase = -68.88%

Minimum Annual Enterprise Value = 39.50M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202551.58M1.68%
202450.72M-68.88%
2023162.98M100.61%
202281.24M-8.08%
202188.38M123.77%
202039.50M-40.29%
201966.14M56.88%
201842.16M0.86%

Annovis Bio, Inc. (ANVS) Average Enterprise Value

How has ANVS Enterprise Value performed in the past?

The current Enterprise Value of Annovis Bio, Inc. (ANVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

88.43M

5-year avg

86.98M

10-year avg

69.39M

Annovis Bio, Inc. (ANVS) Enterprise Value vs. Peers

How is ANVS’s Enterprise Value compared to its peers?

Annovis Bio, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (-19627463.00), less than PolyPid Ltd. (40.34M), less than Celularity Inc. (51.87M), greater than BioAtla, Inc. (9.00M), greater than Evaxion Biotech A/S (7.26M), greater than Actinium Pharmaceuticals, Inc. (-8924256.00), less than PDS Biotechnology Corporation (52.81M), less than BioXcel Therapeutics, Inc. (118.31M), greater than Elutia Inc. (20.04M), less than MAIA Biotechnology, Inc. (44.63M),

Build a custom stock screener for Annovis Bio, Inc. (ANVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annovis Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annovis Bio, Inc. (ANVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annovis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Annovis Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Annovis Bio, Inc. (ANVS)?

What is the 3-year average Enterprise Value for Annovis Bio, Inc. (ANVS)?

What is the 5-year average Enterprise Value for Annovis Bio, Inc. (ANVS)?

How does the current Enterprise Value for Annovis Bio, Inc. (ANVS) compare to its historical average?